(Date:11/24/2009)...24/PRNewswire-FirstCall/--Sigma-AldrichCorporation...renceonTuesday,December1stat1:45PMGMTinLondon,7:45...adcastovertheInternetavailableat http://inve s ...ebcast"icontoaccessthisfile. ,, AboutSigma-Al...echnologycompany.Itschemicalandbiochemicalproducts...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Na...elopingandcommercializingnovelpainmanagementtherap...hiefExecutiveOfficer,isscheduledtopresentatthe21st...ember1-2,2009atTheNewYorkPalaceHotelinNewYork,NewY...ncialOfficer,willbeavailabletorespondtoquestionsdu...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,...nomicHealth,sExecutiveChairman,willpresentatthe21s...tyonTuesday,December1,2009at10:00a.m.ET. ,, Toa...sentation,visittheInvestorRelationssectionofGenomi...om .Pleaseconnecttothewebsiteatleast15minutesprior...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2...h,announced that Sustenex(TM), its all-natural dai...e. Each Sustenex(TM) capsule contains at least 2,b...rietary, patented strain,of Bacillus coagulans des.... Sustenex(TM) with GanedenBC30 Probiotic is desig...elivering ten times more probiotic cells,than most...
...egic and operational leadership to support expans... opportunities, COLUMBIA, Md., A...ent of Brad L. Stewart as President of the Company...elops and manufactures research and in,vitro diagn... assay,cell-mediated immunity (CMI)., (Photo: ht...
...e,Chairman and CEO, Egenix, Inc., announced the ap...e company,s scientific advisory board. Dr.,Petryla...Columbia,University Medical Center where he is Dir...l Oncology. He is the co-author of numerous peer r... in the treatment of cancers of,prostate, kidney, ...
Other Biology Technology:Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 2Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 3Cylex Announces Brad L. Stewart as President of the Company 2Toxoplasma IgG ELISA Kit, Single from Bio-Quant Inc.
Agarose, low melting/gelling temperature high MW separation (> 1000 bp) from GE Healthcare, formerly Amersham Biosciences
Rubella IgM ELISA Kit, Single from Bio-Quant Inc.
Chlamydia pneumonia IgA ELISA Kit, Single from Bio-Quant Inc.
Biology Products: